Vivo Capital »

Onkure Therapeutics Inc-a shares owned by Vivo Capital

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.0M 1.9M 4.14

More positions owned by Vivo Capital

Erasca Common (ERAS)
Praxis Precision Medicines Common (PRAX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
DBV Technologies SA Sponsored Ads (DBVT)
Compass Therapeutics Common (CMPX)
Tango Therapeutics Common (TNGX)
SAB Biotherapeutics Common (SABS)
Corvus Pharmaceuticals Holdings Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Dianthus Therapeutics Common (DNTH)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Minerva Neurosciences Common (NERV)

View all positions for Vivo Capital

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
Prosight Management
BVF
Vivo Capital
Vestal Point Capital
Foresite Capital Management VI
Adage Capital Partners GP
Sio Capital Management
Vanguard Capital Management
NEA Management Company
Rosalind Advisors
Renaissance Technologies

View all funds holding Onkure Therapeutics Inc-a